NeuroLex Laboratories, Inc develops voice analysis technology that tracks mental, cognitive and respiratory health from Boston.
Founded in 2016 and headquartered in Boston, US, NeuroLex Laboratories, Inc develops a vocal biomarker platform that analyzes voice data with audio signal processing and machine learning. It tracks mental, cognitive and respiratory health, mainly for organizations focused on workforce wellness, especially in blue-collar sectors. Revenue comes from partnerships and tiered subscriptions. The company was acquired by Sonde Health, Inc. in January 2015.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in